Cargando…

Combined Impact of Inflammation and Pharmacogenomic Variants on Voriconazole Trough Concentrations: A Meta-Analysis of Individual Data

Few studies have simultaneously investigated the impact of inflammation and genetic polymorphisms of cytochromes P450 2C19 and 3A4 on voriconazole trough concentrations. We aimed to define the respective impact of inflammation and genetic polymorphisms on voriconazole exposure by performing individu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bolcato, Léa, Khouri, Charles, Veringa, Anette, Alffenaar, Jan Willem C., Yamada, Takahiro, Naito, Takafumi, Lamoureux, Fabien, Fonrose, Xavier, Stanke-Labesque, Françoise, Gautier-Veyret, Elodie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152514/ https://www.ncbi.nlm.nih.gov/pubmed/34068031 http://dx.doi.org/10.3390/jcm10102089

Ejemplares similares

Variability of Isavuconazole Trough Concentrations during Longitudinal Therapeutic Drug Monitoring
por: Bolcato, Léa, et al.
Publicado: (2022)

Variability of Tacrolimus Trough Concentration in Liver Transplant Patients: Which Role of Inflammation?
por: Chavant, Anaelle, et al.
Publicado: (2021)

The effect of inflammation on voriconazole trough concentrations in children
por: ter Avest, Mendy, et al.
Publicado: (2016)

Tocilizumab Trough Levels Variability in Kidney-Transplant Candidates Undergoing Desensitization
por: Truffot, Aurélie, et al.
Publicado: (2021)

Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment
por: Stanke-Labesque, Françoise, et al.
Publicado: (2020)

Modifications pharmacocinétiques liées à une infection aiguë. Exemples issus de la pandémie de SARS-CoV-2
por: Chavant, Anaëlle, et al.
Publicado: (2021)

Early Exposure of Kidney Transplant Recipients with Chronic Antibody-Mediated Rejection to Tocilizumab—A Preliminary Study
por: Arrivé, Capucine, et al.
Publicado: (2023)

Factors Affecting Voriconazole Trough Concentration and Optimal Maintenance Voriconazole Dose in Chinese Children
por: Zhao, Yi-Chang, et al.
Publicado: (2021)

Neglecting Plasma Protein Binding in COVID‐19 Patients Leads to a Wrong Interpretation of Lopinavir Overexposure
por: Stanke‐Labesque, Francoise, et al.
Publicado: (2021)

Predictors of Adverse Events and Determinants of the Voriconazole Trough Concentration in Kidney Transplantation Recipients
por: Zhao, Yi‐Chang, et al.
Publicado: (2020)

Moderate correlation between systemic IL‐6 responses and CRP with trough concentrations of voriconazole
por: Vreugdenhil, Bas, et al.
Publicado: (2018)

Remission of hepatotoxicity in chronic pulmonary aspergillosis patients after lowering trough concentration of voriconazole
por: Teng, Guo-Jie, et al.
Publicado: (2020)

Interactive Effects of Glucocorticoids and Cytochrome P450 Polymorphisms on the Plasma Trough Concentrations of Voriconazole
por: Jia, Su-jie, et al.
Publicado: (2021)

Decrease of voriconazole trough levels during therapy with enteral nutrition: a case report
por: Kaneko, Hiromi, et al.
Publicado: (2022)

Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis
por: Jin, Haiying, et al.
Publicado: (2016)

Association of Voriconazole Trough Plasma Concentration with Efficacy and Incidence of Hepatotoxicity in Iranian Patients with Hematological Malignancies
por: Taghvaye-masoumi, Hamidreza, et al.
Publicado: (2021)

Leukotriene Production Is Increased in Abdominal Obesity
por: Bäck, Magnus, et al.
Publicado: (2014)

Voriconazole-induced photocarcinogenesis is promoted by aryl hydrocarbon receptor-dependent COX-2 upregulation
por: Ikeya, Shigeki, et al.
Publicado: (2018)

Predictors of Voriconazole Trough Concentrations in Patients with Child–Pugh Class C Cirrhosis: A Prospective Study
por: Zhao, Yichang, et al.
Publicado: (2021)

Therapeutic Drug Monitoring of Sputum Voriconazole in Pulmonary Aspergillosis
por: Sarfati, Sacha, et al.
Publicado: (2022)

Preservation of epoxyeicosatrienoic acid bioavailability prevents renal allograft dysfunction and cardiovascular alterations in kidney transplant recipients
por: Duflot, Thomas, et al.
Publicado: (2021)

Generalized exfoliative skin rash as an early predictor of supratherapeutic voriconazole trough levels in a leukemic child: A case report
por: Amanati, Ali, et al.
Publicado: (2020)

Analysis of Combined Effect of CYP2C19 Genetic Polymorphism and Proton Pump Inhibitors Coadministration on Trough Concentration of Voriconazole
por: Mafuru, Magesa, et al.
Publicado: (2021)

Saliva for Precision Dosing of Antifungal Drugs: Saliva Population PK Model for Voriconazole Based on a Systematic Review.
por: Kim, Hannah Yejin, et al.
Publicado: (2020)

Pharmacogenomic testing: perception of clinical utility, enablers and barriers to adoption in Australian hospitals
por: Pearce, Angela, et al.
Publicado: (2022)

Of waves and troughs
por: Noll-Hussong, Michael
Publicado: (2014)

Therapeutic Drug Monitoring of Posaconazole: an Update
por: Dekkers, Bart G. J., et al.
Publicado: (2016)

Posaconazole therapeutic drug monitoring in clinical practice and longitudinal analysis of the effect of routine laboratory measurements on posaconazole concentrations
por: Märtson, Anne‐Grete, et al.
Publicado: (2019)

Favorable Effects of Voriconazole Trough Concentrations Exceeding 1 μg/mL on Treatment Success and All-Cause Mortality: A Systematic Review and Meta-Analysis
por: Hanai, Yuki, et al.
Publicado: (2021)

Street Troughs and Glanders
Publicado: (1892)

Danger in the Water Trough
Publicado: (1885)

Caspofungin Weight-Based Dosing Supported by a Population Pharmacokinetic Model in Critically Ill Patients
por: Märtson, Anne-Grete, et al.
Publicado: (2020)

Response of chromoblastomycosis to voriconazole
por: de Lima, Alexandre Moretti, et al.
Publicado: (2016)

Serum voriconazole level variability in patients with hematological malignancies receiving voriconazole therapy
por: Saini, Lalit, et al.
Publicado: (2014)

NPAideS: a drug-checking study among 3-methylmethcathinone (3-MMC) users
por: Willeman, Théo, et al.
Publicado: (2023)

Therapeutic Effect of Intrastromal Voriconazole, Topical Voriconazole, and Topical Natamycin on Fusarium Keratitis in Rabbit
por: Nejabat, Mahmood, et al.
Publicado: (2016)

Invasive trichosporonosis treated with voriconazole
por: Garg, Vaibhav, et al.
Publicado: (2018)

Voriconazole-refractory invasive aspergillosis
por: Park, Se Yoon, et al.
Publicado: (2017)

Voriconazole: Hepatotoxicity: case report
Publicado: (2021)

Voriconazole-Induced Diffuse Periostitis
por: Stefan, Simona, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_msl56fij3l3bdj5edetkfnpai2